Gate2Brain Selected for the EU Business Hub Mission at World Health Expo Osaka 2026
Gate2Brain has been selected to participate in the EU Business Hub Business Mission at World Health Expo (WHX) Osaka 2026, a leading international event that brings together healthcare innovators, industry leaders, investors and decision-makers from around the world.
Organised by the EU Business Hub and funded by the European Union, the mission supports innovative European companies in expanding their international reach, fostering collaboration and exploring new business opportunities in strategic global markets.
Taking place in Osaka, Japan, from 2 to 4 July 2026, WHX Osaka will provide Gate2Brain with a valuable platform to showcase its technology, strengthen its international network and engage with key stakeholders across the healthcare and life sciences sectors.
Gate2Brain is advancing a novel drug delivery platform designed to facilitate the transport of therapeutics across biological barriers. By enabling more efficient delivery of medicines to their intended targets, the company aims to unlock new therapeutic opportunities and contribute to improved treatment options for patients with high unmet medical needs.
As part of the mission, Gate2Brain will exhibit at the EU Pavilion (Hall 6, Zone B, Booth B-1502), joining a select group of European companies showcasing innovative healthcare technologies and solutions.
Participation in this mission represents an important opportunity for Gate2Brain to increase its international visibility, exchange knowledge with global experts and contribute to advancing innovation in drug delivery.
Gate2Brain would like to thank the EU Business Hub for selecting the company for this mission and for supporting the international growth of European innovation.
We look forward to representing Gate2Brain in Osaka and contributing to the strong presence of European healthcare innovation on the global stage.
